Promise Bio
PrivateLast Round
Seed
Dec 16, 2024
Total Funding Raised
$8.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Promise Bio operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Seed round in December 2024.
Promise Bio is a biotechnology company that provides an artificial intelligence-based healthcare platform for epiproteomic analysis to treat immune-mediated diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Precision Medicine, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Promise Bio Comparables
Compare Promise Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Protai | 83% | |
| Bruker | 68% | |
| Illumina, Inc. | 66% |
For institutional investors. Book with your work email.
Promise Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Promise Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Awz Ventures | Seed |
| Israel Innovation Authority | Seed |
| Israel Innovation Authority | Seed |
| Awz Ventures | Seed |
| Pfizer | Seed |
| AION Labs | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 3244% MoM, from 32 to 1.1K.
- Mar 3, 2026
Monthly visitors increased 215% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withSep 17, 2026
Promise partners with Genome Canada as part of established international collaborations with nine sister initiatives.
For institutional investors. Book with your work email.
Promise Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Promise Bio's valuation, stock price, and market status.
Is Promise Bio a public or private company?
Promise Bio is a private company.
What is the current stock price of Promise Bio?
Promise Bio is a private company, so its shares have no public market price. Caplight tracks Promise Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Promise Bio worth (valuation)?
Valuation information for Promise Bio is not publicly available.
Can I buy Promise Bio stock?
Promise Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Promise Bio's last funding round?
Promise Bio's most recent funding round was Seed on December 16, 2024.
Who are the main investors in Promise Bio?
Key investors in Promise Bio include Awz Ventures, Awz Ventures.
Will Promise Bio IPO soon?
No public IPO plans have been announced for Promise Bio.
How can I track Promise Bio secondary market activity?
Caplight tracks bids, offers, and trades in Promise Bio's shares on secondary markets.